MORE DRUGS added to the Schedule H list Ruby Khatun Khatun9 Nov 2017 11:38 AM ISTThrough a recent gazette notification, Ministry of Health And Family Welfare has extended the list of schedule H drugs by adding more drugs to...
Mylan seeks EMA approval for 2 biosimilars Ruby Khatun Khatun9 Nov 2017 10:32 AM ISTNew Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore Ruby Khatun Khatun9 Nov 2017 10:16 AM ISTNew Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
To market new drugs in India, global trials must include Indians Ruby Khatun Khatun12 Oct 2017 3:21 PM ISTNew Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
Zydus gets USFDA nod for overactive bladder drug Ruby Khatun Khatun6 Oct 2017 9:49 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
Cigna to end OxyContin painkiller coverage, signs contract for alternative Ruby Khatun Khatun6 Oct 2017 9:30 AM ISTAmid a growing U.S. opioid addiction, health insurer Cigna Corp will stop covering OxyContin, the opioid painkiller sold by Purdue Pharma LP, as of...
Integra LifeScience acquires codman neurosurgery business from Johnson and Johnson Ruby Khatun Khatun6 Oct 2017 9:15 AM ISTPLAINSBORO, N.J.: Integra LifeSciences Holdings Corporation, a global leader in medical technology, announced that it has completed the previously...
Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar Ruby Khatun Khatun5 Oct 2017 10:53 AM ISTNew Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 percent in Hyderabad-based Gland Pharma at a valuation of not more than USD...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
Police raid French HQ of pharma giant Merck Ruby Khatun Khatun5 Oct 2017 9:49 AM ISTParis: Police on Tuesday raided the French headquarters of German pharmaceutical giant Merck, the maker of a thyroid drug at the center of a medical...
Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection Ruby Khatun Khatun4 Oct 2017 10:55 AM ISTNew Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
